Vascular endothelial growth factor (VEGF) receptor expression correlates with histologic grade and stage of colorectal cancer

Libyan Journal of Medicine

Volumn 5, Issue 1, 2010, Pages 1-4

  Hashim, Ali F ^a   Al Janabi, As'ad A ^a   Mahdi, Liwaa H ^a   Al Toriahi, Kaswer M ^a   Yasseen, Akeel A ^a,b  

^a UNIVERSITY OF KUFA   (Iraq)

^b UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

Colorectal carcinoma; Immunohistochemistry; VEGF

Indexed keywords

AVIDIN; BIOTIN; FORMALDEHYDE; PARAFFIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ADULT; ARTICLE; CANCER GRADING; CANCER STAGING; CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; EMBEDDING; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN EXPRESSION; TISSUE FIXATION;

EID: 77951155665     PISSN: 19932820     EISSN: 18196357     Source Type: Journal    
DOI: 10.3402/ljm.v5i0.5059     Document Type: Article

References (30)

1. Cristi E, Peerrone G, Toscano G, Verzi A, Nori S, Santini D, et al. Tumor proliferation, angiogenesis, and polidy in human colon cancer. J Clin Pathol. 2005; 58: 1170-4.
2. Jackson-Thompson S, Ahmed F, Germann RR, Lai SM, Friedman C. Descriptive epidemiology of colorectal cancer United States, 1998-2001. Cancer 2006; 107: 1103-11.
3. Iraqi Ministry of Health. Results of Iraqi cancer registry. Baghdad, Iraq; 2004.
4. Kayton ML. Cancer and pediatric inflammatory bowel disease. Semin Pediatr Surg. 2007; 16: 205-13.
5. Zarychanski R, Chen Y, Bernstein CN, Hebert PC. Frequency of colorectal cancer screening and the impact of family physicians on screening behavior. CMAJ 2007; 177: 593-7.
6. Khafagy W, El-Ghazaly M, El-Shobaky MT, Khafagy M. Colorectal cancer in Egypt - does it differ? Coloproctology 2000; 22: 109-15.
7. Bronner MP. Gastrointestinal inherited polyposis syndromes. Mod Pathol. 2003; 16: 359-65.
8. Ahsan H, Neugut AI, Garbowski GC, Jacobson JS, Forde KA, Treat MR, et al. Family history of colorectal adenomatous polyps and increased risk for colorectal carcinoma. Ann Intern Med. 1998; 128: 900-5.
9. Eaden J. Colorectal carcinoma and inflammatory bowel disease. Aliment Pharmacol Ther. 2004; 20: 24-30.
10. Takayama T, Miyanishi K, Hayashi T, Sato Y, Niitsu Y. Colorectal carcinoma: genetic of development and metastasis. J Gastroenterol. 2006; 41: 185-92.
11. Hideki U, Ashley P, Wilkinson HK, Jermy JR, Hidetaka M, Ian TC. A new prognostic staging for rectal cancer. Ann Surg. 2004; 240: 832-9.
12. Shiota G, Ishida M, Noguchi N, Oyama K, Takano Y, Okubo M, et al. Circulating P53 antibody in patients with colorectal carcinoma: relation to clinicopathological features. Dig Dis Sci. 2000; 45: 122-8.
13. Takuya Y, Takao O, Tadashi S, Hiromitsu M, Kazuyuki T, Hirotaka I, et al. Vascular endothelial growth factor (VEGF) as a prognosticator for colorectal cancer. J Jpn Soc Colo-Proctol. 2000; 53: 27-34.
14. Shibuya M. Structure and function of VEGF/VEGF-receptor system involved in angiogenesis. Cell Struct Funct. 2001; 26: 25-35.
15. Holmes DIR, Zachary I. The vascular endothelial growth factor (VEGF) family: angiogenic factor in health disease. Genome Biol. 2005; 6: 209-12.
16. Compton CC, Frderick LG. The staging of colorectal cancer: 2004 and beyond. CA Cancer J Clin. 2004; 54: 295-308.
17. Gluzman-Poltorak Z, Cohen T, Herzog Y, Neufeld G. Neuropilin-2 is a receptor for the vascular endothelial growth factor (VEGF) forms VEGF-145 and VEGF-165. J Biol Chem. 2000; 275: 18040-5.
18. Galizia G, Lieto E, Ferraraccio F, Orditura M, DeVita F, Castellano P, et al. Determination of molecular marker expression can predict clinical outcome in colon carcinomas. Clin Cancer Res. 2004; 10: 3490-9.
19. Roberts J, Tomanek AS, Zheng W, Brock T, Bjercke RJ, Holifield JS. Vascular endothelial growth factor and basic fibroblast growth factor differentially modulate early postnatal coronary angiogenesis. Circ Res. 2001; 88: 1127-34.
20. Hanabata N, Sasaki Y, Tanaka M, Tsuji T, Hatada Y, Munakata A. Vascular endothelial growth factor expression and micro vessel parameters of colonic mucosa correlate with sensitivity to steroid in patients with ulcerative colitis. Scand J Gastroenerol. 2005; 40: 188-93.
21. Tokunaga T, Oshika Y, Aby Y, Ozeki Y, Sadahgiro S, Kijima H, et al. Vascular endothelial growth factor (VEGF) isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer. Br J Cancer 1998; 77: 998-1002.
22. Cascinu S, Staccioli MP, Gasparini G, Giordani P, Catalano V, Ghiselli R, et al. Expression of vascular endothelial growth factor can predict event-free survival in stage II colon cancer. Clin Cancer Res. 2000; 6: 2803-7.
23. Kondo Y, Arii S, Furutani M, Isigami S, Mori A, Onodera H, et al. Implication of vascular endothelial growth factor and P53 status for angiogenesis in non-invasive colorectal carcinoma. Cancer. 2000; 88: 1820-7.
24. Zarychanski R, Chen Y, Bernstein CN, Hebert PC. Frequency of colorectal cancer screening and the impact of family physicians on screening behavior. CMAJ 2007; 177: 573-7.
25. Goethals L, Debucquoy A, Perneel C, Geboes K, Ectors N, De Schutter H, et al. Hypoxia in human colorectal adenocarcinoma: comparison between extrinsic and potential intrinsic hypoxia markers. Int J Radiat Oncol. 2006; 65: 246-54.
26. Ono T, Miki C. Factors influencing tissue concentration of vascular endothelial growth factor in colorectal carcinoma. Am J Gastroenterol. 2000; 95: 1062-7.
27. Gunsilius E, Tswchmelitsch J, Eberweinm M, Schwelberger H, Spizzo G, Kahler CM, et al. In vivo release of vascular endothelial growth factor from colorectal carcinomas. Oncology 2002; 62: 313-7.
28. Saad RS, Liu Y, Nathan G, Celerebezze J, Medich D, Silverman JF. Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in colorectal cancer. Mod Pathol. 2004; 17: 197-203.
29. Landriscina M, Casssano C, Ratto C, Longo R, Ippolit M, Palazzotti B, et al. Quantitative analysis of basic fibroblast growth factor and vascular endothelial growth factor in human colorectal carcinoma. Br J Cancer 1998; 78: 765-77.
30. Nakasaki T, Wada H, Shigemori C, Gabazza EC, Nobori T, Nakamura S, et al. Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer. Am J Hematol. 2002; 69: 247-54.